SkyView Investment Advisors’s Boston Scientific BSX Stock Holding History

SkyView Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,473	Closed	-$296K	–	617
2023 Q2	$296K	Sell	5,473 -1,164	-18%	-$60.8K	0.07%	317
2023 Q1	$332K	Buy	6,637 +12	+0.2%	+$566	0.08%	287
2022 Q4	$307K	Buy	6,625 +91	+1%	+$3.94K	0.09%	274
2022 Q3	$253K	Sell	6,534 -279	-4%	-$11.2K	0.07%	331
2022 Q2	$254K	Sell	6,813 -10,144	-60%	-$413K	0.07%	354
2022 Q1	$731K	Buy	16,957 +8,421	+99%	+$365K	0.17%	178
2021 Q4	$674K	Buy	+8,536	New	+$359K	0.15%	174

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SkyView Investment Advisors's BSX Position: Q3 2023 in Review

SkyView Investment Advisors sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 5,473 shares — an estimated $296K sold.

SkyView Investment Advisors first reported a position in BSX in Q4 2021 and held it in 7 quarters. The position peaked at $731K in Q1 2022. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

SkyView Investment Advisors reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
SkyView Investment Advisors sold 5,473 Boston Scientific shares in Q3 2023, an estimated $296K.
SkyView Investment Advisors first reported a position in Boston Scientific in Q4 2021 and held it in 7 quarters.
SkyView Investment Advisors's Boston Scientific position peaked at $731K in Q1 2022.
1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on SkyView Investment Advisors's 13F filing for Q3 2023, filed 17 Nov 2023.